ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling - a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
Kringelbach T, Højgaard M, Rohrberg K, Spanggaard I, Laursen BE, Ladekarl M, Haslund CA, Harsløf L, Belcaid L, Gehl J, Søndergaard L, Eefsen RL, Hansen KH, Kodahl AR, Jensen LH, Holt MI, Oellegaard TH, Yde CW, Ahlborn LB, Lassen U.
Kringelbach T, et al. Among authors: ladekarl m.
BMC Cancer. 2023 Feb 22;23(1):182. doi: 10.1186/s12885-023-10632-9.
BMC Cancer. 2023.
PMID: 36814246
Free PMC article.
Clinical Trial.